Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous droperidol dose comparison for prevention of postoperative nausea and vomiting after thyroid surgery
2006-005920-18Phase 4Active
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of droperidol in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Complete response. Started Dec 2006; status: active.
02
Drugs
droperidol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on 2006-005920-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005920-18.